Second workshop for the EMEA/CHMP Working Group with Patients' Organisations

• Datum:
  Samstag, 4 Dezember 2004, Ganztägig
• Ort:
  European Medicines Agency, Amsterdam, the Netherlands

On 3 December 2004, the EMEA/CHMP Working Group with Patients' Organisations held aworkshop with representatives from a number of partners and stakeholders, including theEuropean Commission, national competent authorities, patients' organisations, healthcareprofessionals' organisations and pharmaceutical industry. The objective was to discuss therecommendations and proposals for action published for consultation in April 2004.

Documents

Report from the 2nd workshop for the EMEA /CHMP working group with patients organisations

Reference Number: EMEA/17857/2005 Final

Recommendations and proposals for action - Dr Daniel Brasseur

Recommendations in the area of pharmacovigilance - Emmanuel Trenado

Transparency and dissemination of information - Francois Houyvez

General remarks on the recommendations - Dr Frits Lekkerkerker

Recommendations in the area of interaction between EMEA CHMP and Patients Organisations - Dr Isabelle Moulon

Product information recommendations and proposals for action - Lesley Greene